| Microorganism |
|
|
|
| Antimicrobial |
 |
|
Reference |
| Staphylococcus aureus (oxacillin-susceptible) |
0.016 |
0.03 |
0.016 － >16 |
Imipenem |
493 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.03 |
≤0.03 |
≤0.03 － 1 |
Trovafloxacin (Trovan) |
462 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.032 |
0.064 |
? － ? |
Imipenem |
126 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.06 |
0.06 |
0.015 － 2 |
Garenoxacin (T-3811, BMS-284756) |
225 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.06 |
0.12 |
≤0.03 － >4 |
Gatifloxacin (Tequin) |
412 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.06 |
0.12 |
≤0.06 － 0.25 |
Minocycline (Minocycline hydrochloride, Minocin) |
462 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.06 |
0.12 |
? － ? |
Sparfloxacin (AT-4140, Zagam) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.12 |
≤0.06 － >8 |
Clindamycin (Cleocin) |
265 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.12 |
0.06 － 8 |
Minocycline (Minocycline hydrochloride, Minocin) |
476 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.12 |
≤0.12 |
≤0.12 － >16 |
Telithromycin (HMR 3647, RU-66647, Ketek) |
18 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.12 |
? － ? |
Clindamycin (Cleocin) |
39 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.25 |
0.03 － >16 |
Ertapenem (Invanz) |
493 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.25 |
0.06 － 2 |
Levofloxacin (Levaquin, Quixin) |
265 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.25 |
≤0.06 － >8 |
Clindamycin (Cleocin) |
412 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.25 |
≤0.12 － >16 |
Clindamycin (Cleocin) |
18 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.25 |
? － ? |
Cephalothin (Cefalotin, Keflin, Seffin) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.25 |
? － ? |
Meropenem (Merrem) |
171 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.12 |
0.5 |
? － ? |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
403 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.125 |
0.125 |
0.03 － 2 |
Gatifloxacin (Tequin) |
225 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.125 |
0.125 |
0.06 － 0.125 |
PD 0305970 |
225 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.25 |
0.25 |
0.12 － 0.25 |
Tigecycline (GAR-936, Tigacyl) |
462 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.25 |
0.25 |
0.12 － 4 |
Cefdinir (Omnicef, Cefdiel) |
267 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.25 |
0.25 |
0.125 － 0.25 |
PD 0326448 |
225 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.25 |
0.25 |
0.125 － 4 |
Levofloxacin (Levaquin, Quixin) |
225 |
| Staphylococcus aureus (oxacillin-susceptible) |
≤0.25 |
≤0.25 |
≤0.25 － >16 |
Clindamycin (Cleocin) |
496 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.25 |
0.5 |
0.03 － >16 |
Ciprofloxacin (Cipro, Ciproxin, Ciprobay) |
493 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.25 |
0.5 |
≤0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
496 |
| Staphylococcus aureus (oxacillin-susceptible) |
0.25 |
0.5 |
0.12 － 0.5 |
Quinupristin/Dalfopristin (Synercid) |
265 |